Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers ≤2 cm

Michela Perrino, Guia Vannucchi, Leonardo Vicentini, Gianmaria Cantoni, Davide Dazzi, Carla Colombo, Marcello Rodari, Arturo Chiti, Paolo Beck-Peccoz, Laura Fugazzola

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The incidence of papillary thyroid cancer (PTC) is rapidly growing, the recorded increase being mainly related to tumors ≤2 cm. The re-classification of tumors >1 and ≤2 cm limited to the thyroid from the T2 to the T1 category triggered some concerns about their best management. In order to identify possible predictors of disease outcome, several clinico-pathological features were analyzed by uni- and multivariate analyses in a retrospective consecutive series of 251 PTCs ≤2 cm. Moreover, since 37% of cases were submitted to prophylactic central compartment node dissection (CLND, VI-VII levels) and radioiodine ablation was performed only when the tumor had an extrathyroidal extension, the impact of these therapeutic tools on the final outcome was evaluated. Among all outcome predictors analyzed, only lymph node metastases and extracapsular invasion were strongly associated with persistence/recurrence. It is worth noting that neither age nor tumor size was a significant indicator of the outcome. Interestingly, as far as the therapeutic interventions are concerned, CLND was strongly associated with remission, whereas radioiodine ablation did not influence the outcome. In conclusion, present results confirm the prognostic influence of node metastases and extra-thyroidal invasion, indicating the need for aggressive treatment in tumors extending beyond the capsule. On the contrary, all pT1N0 tumors, regardless of the diameter, the number of intrathyroidal foci, and the age can be effectively treated only by surgery. The major impact of prophylactic CLND on prognosis suggests to routinely associate it to total thyroidectomy in cases with a preoperative diagnosis of malignancy.

Original languageEnglish
Pages (from-to)201-210
Number of pages10
JournalEndocrine-Related Cancer
Volume16
Issue number1
DOIs
Publication statusPublished - 2009

Fingerprint

Dissection
Neoplasms
Neoplasm Metastasis
Factor IX
Thyroidectomy
Papillary Thyroid cancer
Capsules
Thyroid Gland
Multivariate Analysis
Lymph Nodes
Recurrence
Incidence
Therapeutics

ASJC Scopus subject areas

  • Endocrinology
  • Oncology
  • Cancer Research
  • Endocrinology, Diabetes and Metabolism

Cite this

Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers ≤2 cm. / Perrino, Michela; Vannucchi, Guia; Vicentini, Leonardo; Cantoni, Gianmaria; Dazzi, Davide; Colombo, Carla; Rodari, Marcello; Chiti, Arturo; Beck-Peccoz, Paolo; Fugazzola, Laura.

In: Endocrine-Related Cancer, Vol. 16, No. 1, 2009, p. 201-210.

Research output: Contribution to journalArticle

Perrino, Michela ; Vannucchi, Guia ; Vicentini, Leonardo ; Cantoni, Gianmaria ; Dazzi, Davide ; Colombo, Carla ; Rodari, Marcello ; Chiti, Arturo ; Beck-Peccoz, Paolo ; Fugazzola, Laura. / Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers ≤2 cm. In: Endocrine-Related Cancer. 2009 ; Vol. 16, No. 1. pp. 201-210.
@article{ece7cdded5d44a40b9c6b36ef49aca25,
title = "Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers ≤2 cm",
abstract = "The incidence of papillary thyroid cancer (PTC) is rapidly growing, the recorded increase being mainly related to tumors ≤2 cm. The re-classification of tumors >1 and ≤2 cm limited to the thyroid from the T2 to the T1 category triggered some concerns about their best management. In order to identify possible predictors of disease outcome, several clinico-pathological features were analyzed by uni- and multivariate analyses in a retrospective consecutive series of 251 PTCs ≤2 cm. Moreover, since 37{\%} of cases were submitted to prophylactic central compartment node dissection (CLND, VI-VII levels) and radioiodine ablation was performed only when the tumor had an extrathyroidal extension, the impact of these therapeutic tools on the final outcome was evaluated. Among all outcome predictors analyzed, only lymph node metastases and extracapsular invasion were strongly associated with persistence/recurrence. It is worth noting that neither age nor tumor size was a significant indicator of the outcome. Interestingly, as far as the therapeutic interventions are concerned, CLND was strongly associated with remission, whereas radioiodine ablation did not influence the outcome. In conclusion, present results confirm the prognostic influence of node metastases and extra-thyroidal invasion, indicating the need for aggressive treatment in tumors extending beyond the capsule. On the contrary, all pT1N0 tumors, regardless of the diameter, the number of intrathyroidal foci, and the age can be effectively treated only by surgery. The major impact of prophylactic CLND on prognosis suggests to routinely associate it to total thyroidectomy in cases with a preoperative diagnosis of malignancy.",
author = "Michela Perrino and Guia Vannucchi and Leonardo Vicentini and Gianmaria Cantoni and Davide Dazzi and Carla Colombo and Marcello Rodari and Arturo Chiti and Paolo Beck-Peccoz and Laura Fugazzola",
year = "2009",
doi = "10.1677/ERC-08-0119",
language = "English",
volume = "16",
pages = "201--210",
journal = "Endocrine-Related Cancer",
issn = "1351-0088",
publisher = "BioScientifica Ltd.",
number = "1",

}

TY - JOUR

T1 - Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers ≤2 cm

AU - Perrino, Michela

AU - Vannucchi, Guia

AU - Vicentini, Leonardo

AU - Cantoni, Gianmaria

AU - Dazzi, Davide

AU - Colombo, Carla

AU - Rodari, Marcello

AU - Chiti, Arturo

AU - Beck-Peccoz, Paolo

AU - Fugazzola, Laura

PY - 2009

Y1 - 2009

N2 - The incidence of papillary thyroid cancer (PTC) is rapidly growing, the recorded increase being mainly related to tumors ≤2 cm. The re-classification of tumors >1 and ≤2 cm limited to the thyroid from the T2 to the T1 category triggered some concerns about their best management. In order to identify possible predictors of disease outcome, several clinico-pathological features were analyzed by uni- and multivariate analyses in a retrospective consecutive series of 251 PTCs ≤2 cm. Moreover, since 37% of cases were submitted to prophylactic central compartment node dissection (CLND, VI-VII levels) and radioiodine ablation was performed only when the tumor had an extrathyroidal extension, the impact of these therapeutic tools on the final outcome was evaluated. Among all outcome predictors analyzed, only lymph node metastases and extracapsular invasion were strongly associated with persistence/recurrence. It is worth noting that neither age nor tumor size was a significant indicator of the outcome. Interestingly, as far as the therapeutic interventions are concerned, CLND was strongly associated with remission, whereas radioiodine ablation did not influence the outcome. In conclusion, present results confirm the prognostic influence of node metastases and extra-thyroidal invasion, indicating the need for aggressive treatment in tumors extending beyond the capsule. On the contrary, all pT1N0 tumors, regardless of the diameter, the number of intrathyroidal foci, and the age can be effectively treated only by surgery. The major impact of prophylactic CLND on prognosis suggests to routinely associate it to total thyroidectomy in cases with a preoperative diagnosis of malignancy.

AB - The incidence of papillary thyroid cancer (PTC) is rapidly growing, the recorded increase being mainly related to tumors ≤2 cm. The re-classification of tumors >1 and ≤2 cm limited to the thyroid from the T2 to the T1 category triggered some concerns about their best management. In order to identify possible predictors of disease outcome, several clinico-pathological features were analyzed by uni- and multivariate analyses in a retrospective consecutive series of 251 PTCs ≤2 cm. Moreover, since 37% of cases were submitted to prophylactic central compartment node dissection (CLND, VI-VII levels) and radioiodine ablation was performed only when the tumor had an extrathyroidal extension, the impact of these therapeutic tools on the final outcome was evaluated. Among all outcome predictors analyzed, only lymph node metastases and extracapsular invasion were strongly associated with persistence/recurrence. It is worth noting that neither age nor tumor size was a significant indicator of the outcome. Interestingly, as far as the therapeutic interventions are concerned, CLND was strongly associated with remission, whereas radioiodine ablation did not influence the outcome. In conclusion, present results confirm the prognostic influence of node metastases and extra-thyroidal invasion, indicating the need for aggressive treatment in tumors extending beyond the capsule. On the contrary, all pT1N0 tumors, regardless of the diameter, the number of intrathyroidal foci, and the age can be effectively treated only by surgery. The major impact of prophylactic CLND on prognosis suggests to routinely associate it to total thyroidectomy in cases with a preoperative diagnosis of malignancy.

UR - http://www.scopus.com/inward/record.url?scp=65549124975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549124975&partnerID=8YFLogxK

U2 - 10.1677/ERC-08-0119

DO - 10.1677/ERC-08-0119

M3 - Article

VL - 16

SP - 201

EP - 210

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

SN - 1351-0088

IS - 1

ER -